询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
Potassium indol-3-yl sulfate | CAS:2642-37-7
Potassium indol-3-yl sulfate
  • 名称:吲哚-3-基硫酸钾 | Potassium indol-3-yl sulfate
  • CAS号:2642-37-7
  • 别名:Indol-3-ol, potassium sulfate; Indol-3-yl sulfate, potassium salt; Indoxyl sulfate potassium salt
  • 分子式:C8H6NO4S.K
  • 分子量:251.30
  • EINESC号:220-145-5

产品描述

物理化学性质

没有数据没有数据

安全数据

没有数据没有数据

SDS

来源 SDS样本
Alfa-Aesar 浏览或下载
Sigma-Aldrich 浏览或下载
Matrix 浏览或下载
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivation.Sai Vikram Vemula et al.Antiviral research, 139, 161-170 (2016-11-28) Ingenol-3-Angelate Suppresses Growth of Melanoma Cells and Skin Tumor Development by Downregulation of NF-kappaB-Cox2 SignalingWang D and Liu P Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 24, 486-486 (2018) Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites.Hao Guo et al.Science (New York, N.Y.), 370(6516) (2020-10-31) Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir.Jason Neidleman et al.eLife, 9 (2020-09-30) Quantifying the lagged Poincaré plot geometry of ultrashort heart rate variability series: automatic recognition of odor hedonic tone.M Nardelli et al.Medical & biological engineering & computing, 58(5), 1099-1112 (2020-03-13) Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion LymphomaZhou F, et al. Molecular Cancer Therapeutics (2017) Mian Yu et al.Journal of controlled release : official journal of the Controlled Release Society, 304, 242-258 (2019-05-10)Cancer-Immunotherapy was the most exciting topic. However, either insensitivity due to singleness of therapeutic target or immune evasion leads to the failure of the treatment. Ingenol-3-mebutate (I3A) can inhibit cancer through synergy between immunotherapy and chemotherapy, however, the speculation and... Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4+ T cells ex vivo.Dawei Zhou et al.Science advances, 6(29), eaba1941-eaba1941 (2020-08-25) Development of a solid-phase extraction method with simple MEKC-UV analysis for simultaneous detection of indole metabolites in human urine after administration of indole dietary supplement.Apichai Phonchai et al.Talanta, 174, 314-319 (2017-07-26) Compounds producing an effective combinatorial regimen for disruption of HIV-1 latency.Pargol Hashemi et al.EMBO molecular medicine, 10(2), 160-174 (2017-12-17) Dopamine receptor antagonists as potential therapeutic agents for ADPKD.Parama Paul et al.PloS one, 14(5), e0216220-e0216220 (2019-05-07) Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations.Judith Grau-Expósito et al.PLoS pathogens, 15(8), e1007991-e1007991 (2019-08-20) Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection.Feng Hsiao et al.PLoS pathogens, 16(4), e1008450-e1008450 (2020-05-01) Rapid measurement of indole levels in Brassica vegetables using one millilitre binary organic extraction solvent and capillary electrophoresis-UV analysis.Suparman et al.Phytochemical analysis : PCA, 31(4), 522-530 (2020-01-09) Notch3/VEGF-A axis is involved in TAT-mediated proliferation of pulmonary artery smooth muscle cells: Implications for HIV-associated PAH.Ming-Lei Guo et al.Cell death discovery, 4, 22-22 (2018-08-16) Effects of αTAT1 and HDAC5 on axonal regeneration in adult neurons.Shen Lin et al.PloS one, 12(5), e0177496-e0177496 (2017-05-16) RasGRPs are targets of the anti-cancer agent ingenol-3-angelate.Xiaohua Song et al.PloS one, 8(8), e72331-e72331 (2013-08-31) Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE-/- mice.Yunci Ma et al.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 113, 108753-108753 (2019-03-12)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交